Accelerant (ARX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 May, 2026Executive summary
Exchange Written Premium reached $1.1B in Q4 2025 (up 24% YoY) and $4.2B for the full year (up 35% YoY), exceeding guidance on all key metrics.
Adjusted EBITDA for Q4 was $71M (up 52% YoY, 28% margin); full year Adjusted EBITDA was $282M (up 149% YoY, 31% margin).
Member count grew to 280 at year-end, with 15 new members added in Q4 and a 29% YoY increase.
Third-party written premium rose to 40% of Exchange Written Premium in Q4, up from 21% in the prior year quarter.
AI-driven platform and proprietary data drive underwriting, portfolio management, and operational efficiency.
Financial highlights
Q4 2025 revenue was $248M, up 30% YoY; full-year revenue reached $913M, up 51% YoY.
Gross loss ratio improved to 51.4% in Q4 2025 from 57.8% in Q4 2024; full-year gross loss ratio was 51%.
Adjusted net income for Q4 was $51M ($0.23 per share); full-year adjusted net income was $179M ($0.93 per share).
Free cash flow conversion reached 87% for the year, generating $157M of unrestricted, unlevered free cash flow.
Net income for the full year 2025 was a loss of $1,345.2M, primarily due to non-recurring IPO-related expenses.
Outlook and guidance
Q1 2026 guidance: Exchange Written Premium of $1.07B–$1.13B, third-party direct written premium of $450M–$470M, Adjusted EBITDA of $64M–$66M.
Full-year 2026 guidance: Exchange Written Premium of at least $5.1B, third-party direct written premium of at least $2.2B, Adjusted EBITDA of at least $275M.
Expect continued shift toward fee-based segments and higher third-party premium proportion.
Loss ratio performance expected to remain in line with previous years.
Latest events from Accelerant
- Shareholders will vote on director elections and auditor ratification at the May 2026 meeting.ARX
Proxy filing30 Mar 2026 - Shareholders will vote on director elections and auditor ratification, with robust governance and oversight.ARX
Proxy filing30 Mar 2026 - Accelerant's IPO leverages a tech-driven insurance platform, targeting $355M in proceeds and rapid growth.ARX
Registration Filing29 Nov 2025 - Executive agreements set high base pay, strong severance, equity, and compliance terms.ARX
Registration Filing29 Nov 2025 - Tech-driven specialty insurance platform targets growth with IPO, but faces execution and regulatory risks.ARX
Registration Filing29 Nov 2025 - Q2 2025 delivered 42% premium growth, 29% EBITDA margin, and a return to profitability.ARX
Q2 202523 Nov 2025 - Adjusted EBITDA up 302% and Exchange Written Premium up 17% year-over-year.ARX
Q3 202514 Nov 2025 - Rapid growth, strong margins, and AI-driven efficiency define this specialty insurance platform.ARX
Investor Presentation11 Sep 2025